{"id":285,"date":"2017-05-15T09:10:00","date_gmt":"2017-05-15T00:10:00","guid":{"rendered":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/2017\/05\/15\/201628\/"},"modified":"2017-09-06T11:25:27","modified_gmt":"2017-09-06T02:25:27","slug":"201628","status":"publish","type":"post","link":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/achievement\/20170515285\/","title":{"rendered":"2016\u5e74\uff08\u5e73\u621028\u5e74\u5ea6\uff09\u306e\u7814\u7a76\u696d\u7e3e"},"content":{"rendered":"<h3 class=\"subjectBasic\">A. \u8ad6\u6587<\/h3>\n<h4>\u3010\u8457\u66f8\u3011<\/h4>\n<ol>\n<li>\u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. \u7b2c\uff13\u7ae0\u3000\u8a3a\u5bdf\u3068\u691c\u67fb\u306e\u624b\u6280\u3092\u5b66\u3076\u3000B. \u4e00\u822c\u81e8\u5e8a\u691c\u67fb\u3000\uff12. \u672b\u68a2\u8840. \u81a0\u539f\u75c5\u30fb\u30ea\u30a6\u30de\u30c1\u30fb\u30a2\u30ec\u30eb\u30ae\u30fc\u3000\u7814\u4fee\u30ce\u30fc\u30c8. \u8a3a\u65ad\u3068\u6cbb\u7642\u793e, \u6771\u4eac. 2016; 94-95.<\/li>\n<\/ol>\n<h4>\u3010\u539f\u8457\u3011<\/h4>\n<ol>\n<li>Ichiro Takajo, Tsuyoshi Sekizuka, Hiromi Fujita, Ayako Kawano, Takeshi Kawaguchi, Motohiro Matsuda, Kazuyoshi Kubo, Shunichi Miyauchi, Kunihiko Umekita, Yasuhiro Nagatomo, Makoto Kuroda, Tomohiko Takasaki, Akihiko Okayama, Shuji Ando. Possible Case of Novel Spotted Fever Group Rickettsiosis in Traveler Returning to Japan from India. Emerging Infectious Diseases. 2016; 22(6): 1079-1082.<\/li>\n<li>\u4f50\u4f2f\u88d5\u4e8c, \u6b66\u7530\u5c55\u5e78, \u5c71\u7530\u660e\u8f1d, \u52a0\u6765\u6075, \u6885\u6728\u4e00\u7f8e, \u5c71\u672c\u6210\u90ce, \u5ca1\u5c71\u662d\u5f66. BD MAX MRSA XT \u30ad\u30c3\u30c8\u3092\u7528\u3044\u305f\u3000Methicillin-resistant\u3000Staphylococcus aureus \u306e\u7279\u7570\u7684\u691c\u51fa. \u6a5f\u5668\u30fb\u8a66\u85ac. 2016; 39(6): 635-640. (12\u6708)<\/li>\n<li>Hashikura Y, Umeki K, Umekita K, Nomura H, Yamada A, Yamamoto I, Hasegawa H, Yanagihara K, Okayama A. Infection of defective human T-lymphotropic virus type 1. Hum Cell. 2017 Apr; 30(2): 117-123.<\/li>\n<li>Umeki K, Umekita K, Hashikura Y, Yamamoto I, Kubo K, Nagatomo Y, Okayama A. Evaluation of Line Immunoassay to Detect HTLV-1 Infection in an Endemic Area, Southwestern Japan; Comparison with Polymerase Chain Reaction and Western Blot. Clin. Lab. 2017 Feb 1;63(2): 227-233.<\/li>\n<li>Taniguchi T, Saeki Y, Okayama A, Hayashi T, Misawa N. Extraintestinal infection of Helicobacter cinaedi induced by oral administration to Balb\/c mice. Microbiol Immunol. 2017 Feb;61(2):57-63.<\/li>\n<li>Fukui S, Nakamura H, Takahashi Y, Iwamoto N, Hasegawa H, Yanagihara K, Nakamura T, Okayama A, Kawakami A. Tumor necrosis factor alpha inhibitors have no effect on a human T-lymphotropic virus type-I (HTLV-I)-infected cell line from patients with HTLV-I-associated myelopathy. BMC Immunol. 2017 Feb 3; 18(1): 7.<\/li>\n<\/ol>\n<h4>\u3010\u75c7\u4f8b\u5831\u544a\uff08\u8ad6\u6587\uff09\u3011<\/h4>\n<ol>\n<li>\u6885\u5317\u4f73\u5b50, \u6625\u5c71\u5e78\u5b8f, \u897f\u5ddd\u7f8e\u7531\u7d00, \u983c\u7530\u9855\u8f9e, \u65ed\u5409\u96c5\u79c0, \u7530\u4e2d\u5f18\u4e4b, \u79cb\u5c71\u88d5, \u5ca1\u5c71\u662d\u5f66, \u7247\u5ca1\u5bdb\u7ae0. \u7537\u6027\u306b\u767a\u75c7\u3057\u305fnonmucinous cystadenoma of the pancreas with pancreatobiliary phenotype and ovarian-like stroma \u3068\u8003\u3048\u3089\u308c\u305f1\u75c7\u4f8b. \u8a3a\u65ad\u75c5\u7406. 2016; 33(2): 170-173. (4\u6708)<\/li>\n<li>\u6cb3\u91ce\u5f69\u5b50, \u6885\u5317\u90a6\u5f66, \u5c0f\u6751\u771f\u592e, \u5ca9\u5c3e\u6d69\u662d, \u677e\u7530\u57fa\u5f18, \u4e45\u4fdd\u548c\u7fa9, \u5bae\u5185\u4fca\u4e00, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5869\u898b\u4e00\u525b, \u897f\u91ce\u4e00\u4e09, \u5ca1\u5c71\u662d\u5f66. \u7b4b\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\u3068\u306e\u9451\u5225\u3092\u8981\u3057\u3001\u7d4c\u53e3\u30b9\u30c6\u30ed\u30a4\u30c9\u304a\u3088\u3073\u30bf\u30af\u30ed\u30ea\u30e0\u30b9\u4f75\u7528\u7642\u6cd5\u304c\u594f\u529f\u3057\u305f\u6297SRP\u6297\u4f53\u967d\u6027\u30df\u30aa\u30d1\u30c1\u30fc\u306e1\u4f8b. \u4e5d\u5dde\u30ea\u30a6\u30de\u30c1. 2017; 37(1): 72-79. (3\u6708)<\/li>\n<li>\u5c0f\u6751\u771f\u592e, \u5bae\u5185\u4fca\u4e00, \u5ca9\u5c3e\u6d69\u662d, \u6cb3\u91ce\u5f69\u5b50, \u677e\u7530\u57fa\u5f18, \u4e45\u4fdd\u548c\u7fa9, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66, \u4e38\u5c71\u6cbb\u5f66. \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u6cbb\u7642\u4e2d\u306b\u767a\u75c7\u3057\u305f\u30a6\u30a8\u30b9\u30c6\u30eb\u30de\u30f3\u80ba\u5438\u866b\u75c7. \u5bae\u5d0e\u770c\u5185\u79d1\u533b\u4f1a\u8a8c. 2017; 91: 11-15. (3\u6708)<\/li>\n<\/ol>\n<h4>\u3010\u7dcf\u8aac\u3011<\/h4>\n<ol>\n<li>\u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. \u8840\u6db2\u691c\u67fb\u3000\u8840\u6db2\u4e00\u822c\u691c\u67fb. \u81e8\u5e8a\u3068\u7814\u7a76. 2016; 93(8): 1050-1055. (8\u6708)<\/li>\n<li>\u5ca1\u5c71\u662d\u5f66, \u6885\u5317\u90a6\u5f66. HTLV-1\u611f\u67d3\u3068\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1. \u81e8\u5e8a\u514d\u75ab\u30fb\u30a2\u30ec\u30eb\u30ae\u30fc\u79d1. 2016; 66(5): 428-433. (11\u6708)<\/li>\n<li>\u6885\u6728\u4e00\u7f8e, \u5ca1\u5c71\u662d\u5f66. 1.HTLV-1\u3068\u305d\u306e\u691c\u67fb\u6cd5. \u65e5\u672c\u691c\u67fb\u8840\u6db2\u5b66\u4f1a\u96d1\u8a8c. 2017; 18(1): 96-104. (2\u6708)<\/li>\n<\/ol>\n<p>&#8211;<\/p>\n<div class=\"pagetop-entry\"><a href=\"#wrapper\"><img loading=\"lazy\" alt=\"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\" src=\"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/files\/2017\/07\/btn-pagetop1.gif\" width=\"123\" height=\"24\" \/><\/a><\/div>\n<h3 class=\"subjectBasic\">B. \u767a\u8868<\/h3>\n<h4>\u3010\u5b66\u4f1a\u767a\u8868\u3011<\/h4>\n<ol>\n<li>\u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u591a\u767a\u6027\u7b4b\u708e\/\u76ae\u819a\u7b4b\u708e\uff08PM\/DM\uff09\u306b\u5408\u4f75\u3057\u305f\u6297ARS\u6297\u4f53\u967d\u6027\u9593\u8cea\u6027\u80ba\u708e\uff08IP\uff09\u306e\u691c\u8a0e. \u7b2c56\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. \u81a0\u539f\u75c5IP\u30fb\u8840\u7ba1\u708e1. PP185. 2016. \uff084\u67088-10\u65e5\uff088\u65e5\u767a\u8868\uff09, \u4eac\u90fd\u5e9c\u4eac\u90fd\u5e02, \u56fd\u7acb\u4eac\u90fd\u56fd\u969b\u4f1a\u9928\uff09<\/li>\n<li>\u59eb\u8def\u5927\u8f14, \u5ddd\u53e3\u525b, \u767d\u6ff1\u77e5\u5e83, \u5c71\u4e2d\u7be4\u5fd7. \u9ad8\u5ea6\u6162\u6027\u814e\u4e0d\u5168\u306b\u5408\u4f75\u3057\u305f\u80ba\u764c\u75c7\u4f8b\u306e\u81e8\u5e8a\u7684\u691c\u8a0e. \u7b2c56\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. \u80ba\u764c\u30fb\u5408\u4f75\u75c7. PP414. 2016. \uff084\u67088-10\u65e5\uff088\u65e5\u767a\u8868\uff09, \u4eac\u90fd\u5e9c\u4eac\u90fd\u5e02, \u56fd\u7acb\u4eac\u90fd\u56fd\u969b\u4f1a\u9928\uff09<\/li>\n<li>\u5ddd\u53e3\u525b, \u767d\u6ff1\u77e5\u5e83, \u59eb\u8def\u5927\u8f14. \u5f53\u9662\u306b\u304a\u3051\u308bALK\u878d\u5408\u907a\u4f1d\u5b50\u967d\u6027\u80ba\u764c10\u4f8b\u306e\u691c\u8a0e. \u7b2c56\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u5b66\u8853\u8b1b\u6f14\u4f1a. \u80ba\u764c\u30fb\u5408\u4f75\u75c7. PP405. 2016. \uff084\u67088-10\u65e5\uff088\u65e5\u767a\u8868\uff09, \u4eac\u90fd\u5e9c\u4eac\u90fd\u5e02, \u56fd\u7acb\u4eac\u90fd\u56fd\u969b\u4f1a\u9928\uff09<\/li>\n<li>\u9ad8\u57ce\u4e00\u90ce, \u6cb3\u91ce\u5f69\u5b50, \u5e73\u539f\u5eb7\u5bff, \u5ca1\u5c71\u662d\u5f66. \u8840\u6db2\u57f9\u990a\u306e\u63a1\u53d6\u90e8\u4f4d\u3068\u6c5a\u67d3\u7387\u306e\u691c\u8a0e. \u7b2c90\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u7dcf\u4f1a. \u6557\u8840\u75c7\u30fb\u83cc\u8840\u75c7\uff15\uff08\u8840\u6db2\u57f9\u990a\u306a\u3069\uff09. P2-048. 2016. \uff084\u670815-16\u65e5\uff0816\u65e5\u767a\u8868\uff09, \u5bae\u57ce\u770c\u4ed9\u53f0\u5e02, \u4ed9\u53f0\u56fd\u969b\u30bb\u30f3\u30bf\u30fc\uff09<\/li>\n<li>\u5927\u5cf6\u826f, \u5bae\u5185\u4fca\u4e00, \u4e2d\u5cf6\u5b5d\u6cbb, \u963f\u90e8\u5f18\u751f, \u576a\u5185\u62e1\u4f38, \u5869\u898b\u4e00\u525b, \u5ca1\u5c71\u662d\u5f66, \u7247\u5ca1\u5bdb\u7ae0. \u30a4\u30f3\u30c9\u304b\u3089\u5e30\u56fd\u76f4\u5f8c\u306b\u767a\u71b1\u3092\u6765\u305f\u3057\u305f\u4f1d\u67d3\u6027\u5358\u6838\u7403\u75c7. \u7b2c113\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u8b1b\u6f14\u4f1a\u3000\u533b\u5b66\u751f\u30fb\u7814\u4fee\u533b\u306e\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u3053\u3068\u306f\u3058\u3081 2016\u6771\u4eac. \u611f\u67d3\u75c7\u2460. 277. 2016. \uff084\u670815-17\u65e5\uff0816\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u6771\u4eac\u56fd\u969b\u30d5\u30a9\u30fc\u30e9\u30e0\uff09<\/li>\n<li>\u9234\u6728\u8cb4\u4e45, \u6885\u5317\u90a6\u5f66, \u798f\u4e95\u7fd4\u4e00, \u5ca9\u672c\u76f4\u6a39, \u4e2d\u6751\u82f1\u6a39, \u5ca1\u7530\u899a\u4e08, \u85e4\u5ddd\u656c\u592a, \u8352\u7267\u4fca\u5e78, \u585a\u7530\u654f\u662d, \u576a\u4e95\u96c5\u5f66, \u677e\u5ca1\u76f4\u6a39, \u4e2d\u5cf6\u5b97\u654f, \u690d\u6728\u5e78\u5b5d, \u6c5f\u53e3\u52dd\u7f8e, \u65e5\u9ad8\u5229\u5f66, \u5ca1\u5c71\u662d\u5f66, \u5ddd\u4e0a\u7d14. \u6297HTLV-1\u6297\u4f53\u306e\u6709\u7121\u304c\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u5bfe\u3059\u308b\u6297TNF\u7642\u6cd5\u3078\u306e\u53cd\u5fdc\u6027\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e\uff1a\u591a\u65bd\u8a2d\u5171\u540c\u7814\u7a76. \u7b2c60\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306e\u6cbb\u7642\uff1a\u611f\u67d3\u75c7. W55-1. 2016. \uff084\u670821-23\u65e5\uff0822\u65e5\u767a\u8868\uff09, \u795e\u5948\u5ddd\u770c\u6a2a\u6d5c\u5e02, \u30d1\u30b7\u30d5\u30a3\u30b3\u6a2a\u6d5c\uff09<\/li>\n<li>\u6a4b\u5834\u5f25\u751f, \u65e5\u9ad8\u5229\u5f66, \u897f\u82f1\u5b50, \u7532\u6590\u6cf0\u6587, \u4e45\u4fdd\u548c\u7fa9, \u9ed2\u7530\u5b8f, \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. \u5f53\u9662\u3067\u306e\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u306b\u304a\u3051\u308b\u751f\u7269\u5b66\u7684\u88fd\u5264\u30b9\u30a4\u30c3\u30c1\u75c7\u4f8b\u306e\u691c\u8a0e. \u7b2c60\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306e\u6cbb\u7642\uff1a\u88fd\u5264\u5909\u66f4. W72-3. 2016. \uff084\u670821-23\u65e5\uff0823\u65e5\u767a\u8868\uff09, \u795e\u5948\u5ddd\u770c\u6a2a\u6d5c\u5e02, \u30d1\u30b7\u30d5\u30a3\u30b3\u6a2a\u6d5c\uff09<\/li>\n<li>\u5ca1\u5c71\u662d\u5f66, \u6885\u5317\u90a6\u5f66, \u5ddd\u4e0a\u7d14. HTLV-1\u967d\u6027\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u8a3a\u5bdf\u306e\u7559\u610f\u70b9. \u7b2c60\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u81e8\u5e8a\u306b\u5f79\u7acb\u3064\u611f\u67d3\u75c7\u3068\u30ea\u30a6\u30de\u30c1\u6027\u75be\u60a3\u306e\u95a2\u9023. S9-2. 2016. \uff084\u670821-23\u65e5\uff0822\u65e5\u767a\u8868\uff09, \u795e\u5948\u5ddd\u770c\u6a2a\u6d5c\u5e02, \u30d1\u30b7\u30d5\u30a3\u30b3\u6a2a\u6d5c\uff09<\/li>\n<li>Kunihiko Umekita, Shunichi Miyauchi, Kazuyoshi Kubo, Ichiro Takajo, Ayako Kawano, Kosho Iwao, Mao Komura, Yasuhiro Nagatomo, Motohiro Matsuda, Akihiko Okayama. A Novel Transcription Factor NFAT5 Plays an Important Role in Toll-like Receptor 4 Signaling Pathway of the Activity of Rheumatoid Arthritis Synovial Fibroblasts. \u7b2c60\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. RA, synovium. ICW-B4-2. 2016. \uff084\u670821-23\u65e5\uff0822\u65e5\u767a\u8868\uff09, \u795e\u5948\u5ddd\u770c\u6a2a\u6d5c\u5e02, \u30d1\u30b7\u30d5\u30a3\u30b3\u6a2a\u6d5c\uff09<\/li>\n<li>\u9ad8\u57ce\u4f73\u4eba\u5b50, \u5bae\u5185\u4fca\u4e00, \u5c0f\u6751\u771f\u592e, \u5ca9\u5c3e\u6d69\u662d, \u6cb3\u91ce\u5f69\u5b50, \u4eee\u5c4b\u88d5\u7f8e, \u677e\u7530\u57fa\u5f18, \u4e45\u4fdd\u548c\u7fa9, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u81a0\u539f\u75c5\u95a2\u9023\u75be\u60a3\u306b\u304a\u3051\u308b\u30b9\u30c6\u30ed\u30a4\u30c9\u6cbb\u7642\u304c\u3082\u305f\u3089\u3059\u8010\u7cd6\u80fd\u5909\u5316. \u7b2c60\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u81e8\u5e8a\uff08\u5185\u79d1\uff09. P2-224. 2016. \uff084\u670821-23\u65e5\uff0822\u65e5\u767a\u8868\uff09, \u795e\u5948\u5ddd\u770c\u6a2a\u6d5c\u5e02, \u30d1\u30b7\u30d5\u30a3\u30b3\u6a2a\u6d5c\uff09<\/li>\n<li>\u6cb3\u91ce\u5f69\u5b50, \u6885\u5317\u90a6\u5f66, \u5c0f\u6751\u771f\u592e, \u5ca9\u5c3e\u6d69\u662d, \u677e\u7530\u57fa\u5f18, \u4e45\u4fdd\u548c\u7fa9, \u5bae\u5185\u4fca\u4e00, \u9ad8\u57ce\u4f73\u4eba\u5b50, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u591a\u767a\u6027\u7b4b\u708e\/\u76ae\u819a\u7b4b\u708e\u306b\u5408\u4f75\u3059\u308b\u9593\u8cea\u6027\u80ba\u708e\u3068\u8840\u6db2\u51dd\u56fa\u7570\u5e38\u306b\u95a2\u3059\u308b\u691c\u8a0e. \u7b2c60\u56de\u65e5\u672c\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u591a\u767a\u6027\u7b4b\u708e\u30fb\u76ae\u819a\u7b4b\u708e 2. P3-165. 2016. \uff084\u670821-23\u65e5\uff0823\u65e5\u767a\u8868\uff09, \u795e\u5948\u5ddd\u770c\u6a2a\u6d5c\u5e02, \u30d1\u30b7\u30d5\u30a3\u30b3\u6a2a\u6d5c\uff09<\/li>\n<li>Kawano A, Umekita K, Matsuda M, Kubo K, Miyauchi S, Komura M, Takajo I, Nagatomo Y, Okayama A. Hypercoagulable state might be induced by alveolar-endothelial damages in interstitial lung disease associated with polymyositis\/dermatomyositis. EULAR 2016. 2016. \uff086\u67088-11\u65e5, London\uff09<\/li>\n<li>Umekita K, Miyauchi S, Matsuda M, Kubo K, Komura M, Nomura H, Kawano A, Umeki K, Takajo I, Nagatomo Y, Frank-Bertoncelj M, Gay R. E, Gay S, Okayama A. A novel transcription factor NFAT5 plays an important role as critical regulator in the inflammatory response of rheumatoid arthritis fibroblasts mediated via toll-like receptor 4 signaling pathways. EULAR 2016. 2016. \uff086\u67088-11\u65e5, London\uff09<\/li>\n<li>\u59eb\u8def\u5927\u8f14, \u5ddd\u53e3\u525b, \u767d\u6ff1\u77e5\u5e83. \u80ba\u672b\u68a2\u75c5\u5909\u306b\u5bfe\u3059\u308bEBUS-GS \u6cd5\u691c\u67fb\u306b\u304a\u3051\u308b\u8d85\u97f3\u6ce2\u753b\u50cf\u5206\u985e\u65b0\u30d1\u30bf\u30fc\u30f3\u8ffd\u52a0\u306e\u8a3a\u65ad\u3078\u306e\u5fdc\u7528. \u7b2c39\u56de\u65e5\u672c\u547c\u5438\u5668\u5185\u8996\u93e1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u672b\u68a2\u80ba\u91ce\u75c5\u5909\u306b\u5bfe\u3059\u308b\u6c17\u7ba1\u652f\u93e1\u30a2\u30d7\u30ed\u30fc\u30c1. SY7-3. 2016. \uff086\u670823-24\u65e5\uff0824\u65e5\u767a\u8868\uff09, \u611b\u77e5\u770c\u540d\u53e4\u5c4b\u5e02, \u540d\u53e4\u5c4b\u56fd\u969b\u4f1a\u8b70\u5834\uff09<\/li>\n<li>\u5ddd\u53e3\u525b, \u767d\u6ff1\u77e5\u5e83, \u59eb\u8def\u5927\u8f14. \u5f53\u9662\u306b\u304a\u3051\u308b\u80ba\u53ca\u3073\u6c17\u7ba1\u652fMALT\u30ea\u30f3\u30d1\u816b6\u4f8b\u306e\u691c\u8a0e. \u7b2c39\u56de\u65e5\u672c\u547c\u5438\u5668\u5185\u8996\u93e1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. \u75c5\u7406\u30fb\u751f\u691c\u2462. P55-3. 2016. \uff086\u670823-24\u65e5\uff0824\u65e5\u767a\u8868\uff09, \u611b\u77e5\u770c\u540d\u53e4\u5c4b\u5e02, \u540d\u53e4\u5c4b\u56fd\u969b\u4f1a\u8b70\u5834\uff09<\/li>\n<li>\u6cb3\u91ce\u731b\u55e3, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18. \u3073\u307e\u3093\u6027\u6c4e\u7d30\u6c17\u7ba1\u652f\u708e\u3068\u8a3a\u65ad\u3055\u308c\u3066\u3044\u305f\u539f\u767a\u6027\u7dda\u6bdb\u904b\u52d5\u4e0d\u5168\u75c7. \u7b2c77\u56de\u65e5\u672c\u547c\u5438\u5668\u5b66\u4f1a\u30fb\u65e5\u672c\u7d50\u6838\u75c5\u5b66\u4f1a\u3000\u65e5\u672c\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9 \/ \u8089\u82bd\u816b\u6027\u75be\u60a3\u5b66\u4f1a\u3000\u4e5d\u5dde\u652f\u90e8\u3000\u590f\u5b63\u5b66\u8853\u8b1b\u6f14\u4f1a. 2016. \uff087\u670822-23\u65e5\uff0822\u65e5\u767a\u8868\uff09, \u798f\u5ca1\u770c\u4e45\u7559\u7c73\u5e02, \u8403\u9999\u5712\u30db\u30c6\u30eb\uff09<\/li>\n<li>\u6afb\u539f\u5927\u667a, \u5ddd\u53e3\u525b, \u59eb\u8def\u5927\u8f14. \u6025\u6027\u547c\u5438\u4e0d\u5168\u3092\u5448\u3057\u3001\u30cd\u30fc\u30b6\u30eb\u30cf\u30a4\u30d5\u30ed\u30fc\uff08NHF\uff09\u4f75\u7528\u6c17\u7ba1\u652f\u93e1\u691c\u67fb\u306b\u3088\u308a\u8a3a\u65ad\u3057\u305f\u80ba\u764c\u306b\u3088\u308b\u764c\u6027\u30ea\u30f3\u30d1\u7ba1\u75c7\u306e\u82e5\u5e74\u5973\u6027\u306e1\u4f8b. \u7b2c314\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a. 2016.\uff088\u67086\u65e5,\u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\uff09<\/li>\n<li>\u5ca9\u5c3e\u6d69\u662d, \u4e45\u4fdd\u548c\u7fa9, \u5c0f\u6751\u771f\u592e, \u6cb3\u91ce\u5f69\u5b50, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u80ba\u30af\u30ea\u30d7\u30c8\u30b3\u30c3\u30ab\u30b9\u75c7\u3092\u6765\u3057\u305f\u7279\u767a\u6027CD4\u30ea\u30f3\u30d1\u7403\u6e1b\u5c11\u75c7. \u7b2c314\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a. 2016. \uff088\u67086\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\uff09<\/li>\n<li>\u5742\u53e3\u4eae\u4ecb, \u95a2\u6839\u679d\u91cc\u5b50, \u9ad8\u6a4b\u8061, \u5bae\u5185\u4fca\u4e00. \u5468\u671f\u7684\u306a\u8179\u75db\u30fb\u767a\u71b1\u3092\u4e3b\u8a34\u3068\u3057\u3066\u6765\u9662\u3057\u3001\u30b3\u30eb\u30d2\u30c1\u30f3\u304c\u594f\u529f\u3057\u305f\u5bb6\u65cf\u6027\u5730\u4e2d\u6d77\u71b1\u306e1\u4f8b. \u7b2c314\u56de\u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a. 2016.(8\u67086\u65e5,\u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8)<\/li>\n<li>\u9234\u6728\u8cb4\u4e45, \u6885\u5317\u90a6\u5f66, \u798f\u4e95\u7fd4\u4e00, \u5ca9\u672c\u76f4\u6a39, \u4e2d\u6751\u79c0\u6a39, \u5ca1\u7530\u899a\u4e08, \u85e4\u5ddd\u656c\u592a, \u8352\u5dfb\u4fca\u5e78, \u585a\u7530\u654f\u662d, \u576a\u4e95\u96c5\u5f66, \u677e\u5ca1\u76f4\u6a39, \u4e2d\u5cf6\u5b97\u654f, \u690d\u6728\u5e78\u5b5d, \u65e5\u9ad9\u5229\u5f66, \u5ca1\u5c71\u662d\u5f66, \u5ddd\u4e0a\u7d14. \u6297HTLV-1\u6297\u4f53\u306e\u6709\u7121\u304c\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u5bfe\u3059\u308b\u6297TNF\u7642\u6cd5\u3078\u306e\u53cd\u5fdc\u6027\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u306b\u3064\u3044\u3066\u306e\u691c\u8a0e. \u7b2c3\u56de\u65e5\u672cHTLV-1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2016. \uff088\u670826-28\u65e5\uff0828\u65e5\u767a\u8868\uff09, \u9e7f\u5150\u5cf6\u770c\u9e7f\u5150\u5cf6\u5e02, \u9e7f\u5150\u5cf6\u770c\u5e02\u753a\u6751\u81ea\u6cbb\u4f1a\u9928\uff09<\/li>\n<li>\u6885\u5317\u90a6\u5f66, \u5bae\u5185\u4fca\u4e00, \u91ce\u6751\u5275, \u6885\u6728\u4e00\u7f8e, \u6a4b\u5009\u60a0\u8f1d, \u4e45\u4fdd\u548c\u7fa9, \u677e\u7530\u57fa\u5f18, \u6cb3\u91ce\u5f69\u5b50, \u5ca9\u5c3e\u6d69\u662d, \u5c0f\u6751\u771f\u592e, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. HTLV-1\u611f\u67d3\u7d30\u80de\u306b\u3088\u308b\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u6ed1\u819c\u7d30\u80de\u306e\u6d3b\u6027\u5316\u6a5f\u69cb. \u7b2c3\u56de\u65e5\u672cHTLV-1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2016. \uff088\u670826-28\u65e5\uff0828\u65e5\u767a\u8868\uff09, \u9e7f\u5150\u5cf6\u770c\u9e7f\u5150\u5cf6\u5e02, \u9e7f\u5150\u5cf6\u770c\u5e02\u753a\u6751\u81ea\u6cbb\u4f1a\u9928\uff09<\/li>\n<li>\u6a4b\u5009\u60a0\u8f1d, \u6885\u6728\u4e00\u7f8e, \u5c71\u7530\u660e\u8f1d, \u5c71\u672c\u6210\u90ce, \u6885\u5317\u90a6\u5f66, \u9577\u8c37\u5ddd\u5bdb\u96c4, \u67f3\u539f\u514b\u7d00, \u5ca1\u5c71\u662d\u5f66. HTLV-1\u6b20\u640d\u30d7\u30ed\u30a6\u30a4\u30eb\u30b9\u306e\u7d30\u80de\u9593\u611f\u67d3. \u7b2c3\u56de\u65e5\u672cHTLV-1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2016. \uff088\u670826-28\u65e5\uff0828\u65e5\u767a\u8868\uff09, \u9e7f\u5150\u5cf6\u770c\u9e7f\u5150\u5cf6\u5e02, \u9e7f\u5150\u5cf6\u770c\u5e02\u753a\u6751\u81ea\u6cbb\u4f1a\u9928\uff09<\/li>\n<li>\u4e2d\u6b66\u5f69\u5b50, \u962a\u672c\u8a13\u4ee3, \u9808\u85e4\u5e78\u592b, \u897f\u7247\u4e00\u6717, \u4e2d\u7551\u65b0\u543e, \u6b66\u672c\u91cd\u6bc5, \u5ca9\u6c38\u6b63\u5b50, \u76f8\u826f\u5eb7\u5b50, \u5929\u91ce\u6b63\u5b8f, \u524d\u7530\u5b8f\u4e00, \u672b\u5ca1\u6804\u4e09\u6717, \u5ca1\u5c71\u662d\u5f66, \u5b87\u90fd\u5bae\u8207, \u4e0b\u7530\u548c\u54c9, \u6e21\u9089\u4fca\u6a39, \u68ee\u4e0b\u548c\u5e83. AlphaLISA\u6cd5\u3092\u7528\u3044\u305f\u8840\u4e2d\u53ef\u6eb6\u578bCADM1\u6e2c\u5b9a\u7cfb\u306e\u958b\u767a\u3068ATL\u306e\u8a3a\u65ad\u5fdc\u7528\u3078\u306e\u691c\u8a0e. \u7b2c3\u56de\u65e5\u672cHTLV-1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2016. \uff088\u670826-28\u65e5\uff0828\u65e5\u767a\u8868\uff09, \u9e7f\u5150\u5cf6\u770c\u9e7f\u5150\u5cf6\u5e02, \u9e7f\u5150\u5cf6\u770c\u5e02\u753a\u6751\u81ea\u6cbb\u4f1a\u9928\uff09<\/li>\n<li>\u6885\u6728\u4e00\u7f8e, \u6a4b\u5009\u60a0\u8f1d, \u5c71\u7530\u660e\u8f1d, \u5c71\u672c\u6210\u90ce, \u6885\u5317\u90a6\u5f66, \u6d5c\u53e3\u529f, \u5ca1\u5c71\u662d\u5f66. HTLV-1\u6297\u4f53\u30a6\u30a8\u30b9\u30bf\u30f3\u30d6\u30ed\u30c3\u30c8\u5224\u5b9a\u4fdd\u7559\u691c\u4f53\u306b\u304a\u3051\u308b\u6838\u9178\u691c\u67fb\u306e\u6709\u52b9\u6027. \u7b2c3\u56de\u65e5\u672cHTLV-1\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2016. \uff088\u670826-28\u65e5\uff0828\u65e5\u767a\u8868\uff09, \u9e7f\u5150\u5cf6\u770c\u9e7f\u5150\u5cf6\u5e02, \u9e7f\u5150\u5cf6\u770c\u5e02\u753a\u6751\u81ea\u6cbb\u4f1a\u9928\uff09<\/li>\n<li>\u9ad8\u57ce\u4e00\u90ce, \u6b66\u7530\u5c55\u5e78, \u4f50\u4f2f\u88d5\u4e8c, \u5ca1\u5c71\u662d\u5f66. \u8840\u6db2\u57f9\u990a\u691c\u67fb\u63a1\u53d6\u90e8\u4f4d\u306e\u691c\u8a0e. \u7b2c63\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a. 2016. \uff089\u67081-4\u65e5\uff082\u65e5\u767a\u8868\uff09, \u5175\u5eab\u770c\u795e\u6238\u5e02, \u795e\u6238\u56fd\u969b\u4f1a\u8b70\u5834\u30fb\u795e\u6238\u56fd\u969b\u5c55\u793a\u5834\u30fb\u795e\u6238\u30dd\u30fc\u30c8\u30d4\u30a2\u30db\u30c6\u30eb\uff09<\/li>\n<li>\u85e4\u5ddd\u6075\u5b50, \u5b88\u7530\u653f\u5ba3, \u732a\u5d0e\u307f\u3055\u304d, \u5ca1\u5c71\u662d\u5f66. \u5f53\u9662\u306b\u304a\u3051\u308bTurn Around Time \uff08TAT\uff09 \u306e\u73fe\u72b6\u3068\u4eca\u5f8c\u306e\u8ab2\u984c. \u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u81ea\u52d5\u5316\u5b66\u4f1a\u7b2c48\u56de\u5927\u4f1a. 2016. \uff089\u670822-24\u65e5\uff0824\u65e5\u767a\u8868\uff09, \u795e\u5948\u5ddd\u770c\u6a2a\u6d5c\u5e02, \u30d1\u30b7\u30d5\u30a3\u30b3\u6a2a\u6d5c\uff09<\/li>\n<li>\u65e5\u9ad9\u5229\u5f66, \u6a4b\u5834\u5f25\u751f, \u897f\u82f1\u5b50, \u7532\u6590\u6cf0\u6587, \u9ed2\u7530\u5b8f. \u9ad8\u9f62\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u306b\u5bfe\u3059\u308b\u751f\u7269\u5b66\u7684\u88fd\u5264\uff17\u5264\u306e\u4f7f\u7528\u80cc\u666f\u3068\uff16\u30f6\u6708\u5f8c\u306e\u52b9\u679c\u6bd4\u8f03. \u7b2c52\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. 2016. \uff089\u67083-4\u65e5\uff083\u65e5\u767a\u8868\uff09, \u718a\u672c\u770c\u718a\u672c\u5e02, \u718a\u672c\u5e02\u6c11\u4f1a\u9928\u30fb\u4e00\u756a\u9928\uff09<\/li>\n<li>\u6a4b\u5834\u5f25\u751f, \u5357\u5bdb\u4e4b, \u9577\u5b89\u82f1\u6cbb, \u4e38\u5c71\u6cbb\u5f66, \u897f\u82f1\u5b50, \u7532\u6590\u6cf0\u6587, \u9ed2\u7530\u5b8f, \u65e5\u9ad9\u5229\u5f66, \u5ca1\u5c71\u662d\u5f66. \u30b4\u30ea\u30e0\u30de\u30d6\u6cbb\u7642\u4e2d\u306b\u7cde\u7dda\u866b\u611f\u67d3\u75c7\u3068\u8a3a\u65ad\u3055\u308c\u305f\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306e\uff11\u4f8b. \u7b2c52\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. 2016. \uff089\u67083-4\u65e5\uff083\u65e5\u767a\u8868\uff09, \u718a\u672c\u770c\u718a\u672c\u5e02, \u718a\u672c\u5e02\u6c11\u4f1a\u9928\u30fb\u4e00\u756a\u9928\uff09<\/li>\n<li>\u5ddd\u7530\u5343\u7d18, \u5c0f\u6751\u771f\u592e, \u4e45\u4fdd\u548c\u7fa9, \u6885\u5317\u90a6\u5f66, \u5ca9\u5c3e\u6d69\u662d, \u6cb3\u91ce\u5f69\u5b50, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u30b9\u30c6\u30ed\u30a4\u30c9\u304c\u8457\u52b9\u3057\u305fTAFRO\u75c7\u5019\u7fa4\u306e\u4e00\u4f8b. \u7b2c52\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. 2016. \uff089\u67083-4\u65e5\uff084\u65e5\u767a\u8868\uff09, \u718a\u672c\u770c\u718a\u672c\u5e02, \u718a\u672c\u5e02\u6c11\u4f1a\u9928\u30fb\u4e00\u756a\u9928\uff09<\/li>\n<li>\u5ca9\u5c3e\u6d69\u662d, \u5bae\u5185\u4fca\u4e00, \u5c0f\u6751\u771f\u592e, \u6cb3\u91ce\u5f69\u5b50, \u4e45\u4fdd\u548c\u7fa9, \u677e\u7530\u57fa\u5f18, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u5fae\u5c0f\u8840\u7ba1\u969c\u5bb3\u75c7\u304a\u3088\u3073\u6557\u8840\u75c7\u3092\u5408\u4f75\u3057\u305f\u5168\u8eab\u6027\u30a8\u30ea\u30c6\u30de\u30c8\u30fc\u30c7\u30b9\u306b\u5bfe\u3057\u8840\u6f3f\u4ea4\u63db\u7642\u6cd5\u306e\u6709\u52b9\u6027\u304c\u793a\u5506\u3055\u308c\u305f\u4e00\u4f8b. \u7b2c52\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. 2016. \uff089\u67083-4\u65e5\uff084\u65e5\u767a\u8868\uff09, \u718a\u672c\u770c\u718a\u672c\u5e02, \u718a\u672c\u5e02\u6c11\u4f1a\u9928\u30fb\u4e00\u756a\u9928\uff09<\/li>\n<li>\u5185\u85e4\u6566, \u4e0a\u7530\u5c1a\u9756, \u5ddd\u53e3\u525b, \u524d\u6751\u5e78\u8f14, \u5e73\u7530\u667a\u4e5f. \u30a2\u30c0\u30ea\u30e0\u30de\u30d6\u306b\u3088\u308b\u6cbb\u7642\u958b\u59cb\u304c\u6709\u52b9\u3060\u3063\u305f\u8178\u7ba1\u30d9\u30fc\u30c1\u30a7\u30c3\u30c8\u306e\u4e00\u4f8b. \u7b2c52\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. 2016. \uff089\u67083-4\u65e5\uff084\u65e5\u767a\u8868\uff09, \u718a\u672c\u770c\u718a\u672c\u5e02, \u718a\u672c\u5e02\u6c11\u4f1a\u9928\u30fb\u4e00\u756a\u9928\uff09<\/li>\n<li>Kawano A, Umekita K, Komura M, Iwao K,Matsuda M, Kubo K, Miyauchi S, Takajo I, Nagatomo Y, Okayama A. Anti-aminoacyl-tRNA synthetase\uff08ARS\uff09antibody seems to be associated with the severity of muscular manifestation and alveolar -endothelial damage. IWAA 2016. poster Session 2, 7.Myopathies and Autoantibodies. 2016. (October\u300011-13(12 presentation), The Westin Miyako Kyoto, Kyoto)<\/li>\n<li>\u5ca1\u5c71\u662d\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u798f\u7530\u771f\u5f13, \u4f50\u4f2f\u7950\u4e8c, \u5e73\u539f\u5eb7\u5bff, \u7b67\u6625\u5948. \u75c5\u9662\u518d\u6574\u5099\u3068\u611f\u67d3\u5bfe\u7b56(\u30a2\u30b9\u30da\u30eb\u30ae\u30eb\u30b9\u5bfe\u7b56\u3092\u4e2d\u5fc3\u306b). \u7b2c86\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c59\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c64\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a. \u6559\u80b2\u8b1b\u6f1413. 2016. (11\u670824-26\u65e5\uff0826\u65e5\u767a\u8868\uff09, \u6c96\u7e04\u770c\u5b9c\u91ce\u6e7e\u5e02, \u6c96\u7e04\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc\u30fb\u5065\u5eb7\u6587\u5316\u6751\u3000\u30ab\u30eb\u30c1\u30e3\u30fc\u30ea\u30be\u30fc\u30c8\u30d5\u30a7\u30b9\u30c8\u30fc\u30cd\uff09<\/li>\n<li>\u6cb3\u91ce\u5f69\u5b50, \u9577\u53cb\u5b89\u5f18, \u5ca9\u5c3e\u6d69\u662d, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u30de\u30a4\u30b3\u30d7\u30e9\u30ba\u30de\u3068\u306e\u91cd\u8907\u611f\u67d3\u3092\u5448\u3057\u305f EB\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\u306e\uff11\u4f8b. \u7b2c86\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c59\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c64\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a. \u30de\u30a4\u30b3\u30d7\u30e9\u30ba\u30de\u611f\u67d3\u75c7 272. 2016. (11\u670824-26\u65e5\uff0825\u65e5\u767a\u8868\uff09, \u6c96\u7e04\u770c\u5b9c\u91ce\u6e7e\u5e02, \u6c96\u7e04\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc\u30fb\u5065\u5eb7\u6587\u5316\u6751\u3000\u30ab\u30eb\u30c1\u30e3\u30fc\u30ea\u30be\u30fc\u30c8\u30d5\u30a7\u30b9\u30c8\u30fc\u30cd\uff09<\/li>\n<li>\u5ddd\u7530 \u5343\u7d18, \u5ca9\u5c3e \u6d69\u662d, \u9ad8\u57ce \u4e00\u90ce, \u5c0f\u6751 \u771f\u592e, \u6cb3\u91ce \u5f69\u5b50, \u677e\u7530 \u57fa\u5f18, \u4e45\u4fdd \u548c\u7fa9, \u5bae\u5185 \u4fca\u4e00, \u6885\u5317 \u90a6\u5f66, \u9577\u53cb \u5b89\u5f18, \u5ca1\u5c71 \u662d\u5f66. \u4e21\u5074\u6027\u9f20\u5f84\u30ea\u30f3\u30d1\u7bc0\u816b\u8139\u3092\u5448\u3057\u305f \u732b\u3072\u3063\u304b\u304d\u75c5. \u7b2c86\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c59\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c64\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a. \u7814\u4fee\u533b\u30bb\u30c3\u30b7\u30e7\u30f35\u3000190. 2016. (11\u670824-26\u65e5\uff0825\u65e5\u767a\u8868\uff09, \u6c96\u7e04\u770c\u5b9c\u91ce\u6e7e\u5e02, \u6c96\u7e04\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc\u30fb\u5065\u5eb7\u6587\u5316\u6751\u3000\u30ab\u30eb\u30c1\u30e3\u30fc\u30ea\u30be\u30fc\u30c8\u30d5\u30a7\u30b9\u30c8\u30fc\u30cd\uff09<\/li>\n<li>\u5e73\u539f\u5eb7\u5bff, \u9ad8\u57ce\u4e00\u90ce, \u6d66\u7530\u4fee\u5e73. TAZ\/PIPC\u306b\u5bfe\u3059\u308bAntimicrobial stewardship program\u306e\u8a55\u4fa1\u3068\u8ab2\u984c. \u7b2c86\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u897f\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c59\u56de\u65e5\u672c\u611f\u67d3\u75c7\u5b66\u4f1a\u4e2d\u65e5\u672c\u5730\u65b9\u4f1a\u5b66\u8853\u96c6\u4f1a \u7b2c64\u56de\u65e5\u672c\u5316\u5b66\u7642\u6cd5\u5b66\u4f1a\u897f\u65e5\u672c\u652f\u90e8\u7dcf\u4f1a. ASP(\u8981\u671b)3\u3000287. 2016. (11\u670824-26\u65e5\uff0825\u65e5\u767a\u8868\uff09, \u6c96\u7e04\u770c\u5b9c\u91ce\u6e7e\u5e02, \u6c96\u7e04\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc\u30fb\u5065\u5eb7\u6587\u5316\u6751\u3000\u30ab\u30eb\u30c1\u30e3\u30fc\u30ea\u30be\u30fc\u30c8\u30d5\u30a7\u30b9\u30c8\u30fc\u30cd\uff09<\/li>\n<li>\u702c\u6238\u53e3\u5065\u4ecb, \u5ddd\u53e3\u525b, \u59eb\u8def\u5927\u8f14. \u6c17\u7ba1\u817a\u69d8\u56a2\u80de\u764c\u306b\u4f34\u3046\u9ad8\u5ea6\u6c17\u7ba1\u72ed\u7a84\u306b\u5bfe\u3057\u3066AERO\u3000StentTM\u3000\u7559\u7f6e\u304c\u6709\u52b9\u3067\u3042\u3063\u305f1\u4f8b. \u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u4e3b\u50ac \u7b2c316\u56de\u4e5d\u5dde\u5730\u65b9\u4f1a. \u521d\u671f\u7814\u4fee\u533b1, 13. 2017. (1\u670821\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u3000\u767e\u5e74\u8b1b\u5802)<\/li>\n<li>\u6ff1\u5ee3\u53cb\u83ef, \u6cb3\u91ce\u5f69\u5b50, \u5ca9\u5c3e\u6d69\u662d, \u5c0f\u6751\u771f\u592e, \u677e\u7530\u57fa\u5f18, \u5bae\u5185\u4fca\u4e00, \u9577\u53cb\u5b89\u5f18, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u5589\u982d\u764c\u3092\u5408\u4f75\u3057\u305f\u6297TIF-1\u03b3\u6297\u4f53\u967d\u6027\u76ae\u819a\u7b4b\u708e. \u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u4e3b\u50ac \u7b2c316\u56de\u4e5d\u5dde\u5730\u65b9\u4f1a. \u521d\u671f\u7814\u4fee\u533b1, 18. 2017. (1\u670821\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u3000\u767e\u5e74\u8b1b\u5802)<\/li>\n<li>\u9ad8\u6a4b\u8061, \u6c38\u53cb\u82f1\u4e4b, \u771e\u5ddd\u660c\u5927, \u6d5c\u7530\u6681\u5b50, \u9ad9\u7530\u614e\u543e, \u4e2d\u5cf6\u5fb9, \u53e4\u8c37\u5b5d, \u690d\u91ce\u8302\u7f8e, \u9060\u85e4\u8c4a, \u9577\u53cb\u5b89\u5f18. \u30ea\u30f3\u30d1\u7403\u523a\u6fc0\u8a66\u9a13(DLST)\u304c\u88ab\u7591\u85ac\u306e\u7279\u5b9a\u306b\u6709\u7528\u3067\u3042\u3063\u305f\u30c8\u30e9\u30de\u30c9\u30fc\u30eb\u5869\u9178\u5869\/\u30a2\u30bb\u30c8\u30a2\u30df\u30ce\u30d5\u30a7\u30f3\u914d\u5408\u9320\u306b\u3088\u308b\u85ac\u5264\u6027\u80ba\u969c\u5bb3\u306e1\u4f8b. \u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u4e3b\u50ac \u7b2c316\u56de\u4e5d\u5dde\u5730\u65b9\u4f1a. \u547c\u5438\u56683, 106. 2017. (1\u670821\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u3000\u767e\u5e74\u8b1b\u5802)<\/li>\n<li>\u677e\u5c3e\u525b\u5fd7, \u5c0f\u677e\u5f18\u5e78, \u677e\u5143\u4fe1\u5f18, \u4e2d\u5cf6\u5b5d\u6cbb, \u9ad8\u57ce\u4e00\u90ce, \u8c37\u53e3\u6676\u4fca, \u6960\u5143\u5bff\u5178, \u9ad8\u6a4b\u8061. \u5bae\u5d0e\u304b\u3089\u306e\u6311\u6226\u72b6\uff01\u75c7\u4f8b\u30af\u30a4\u30ba\u3067\u81e8\u5e8a\u63a8\u8ad6\u529b\u30d6\u30e9\u30c3\u30b7\u30e5\u30a2\u30c3\u30d7. \u65e5\u672c\u5185\u79d1\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u4e3b\u50ac \u7b2c316\u56de\u4e5d\u5dde\u5730\u65b9\u4f1a. \u6559\u80b2\u30bb\u30df\u30ca\u30fc. 2017. (1\u670821\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u4e5d\u5dde\u5927\u5b66\u533b\u5b66\u90e8\u3000\u767e\u5e74\u8b1b\u5802)<\/li>\n<li>\u798f\u7530\u771f\u5f13, \u7b67\u6625\u5948, \u5e73\u539f\u5eb7\u5bff, \u4f50\u4f2f\u88d5\u4e8c, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. Bacillus cereus \u8840\u6d41\u611f\u67d3\u4e88\u9632\u3068\u5916\u90e8\u59d4\u8a17\u6d17\u6fef\u696d\u8005\u3078\u306e\u4ecb\u5165. \u7b2c32\u56de\u65e5\u672c\u74b0\u5883\u611f\u67d3\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u30b0\u30e9\u30e0\u967d\u6027\u83cc(VRE\u306a\u3069), 1-P5-2. 2017. (2\u670824-25\u65e5(24\u65e5\u767a\u8868), \u5175\u5eab\u770c\u795e\u6238\u5e02, \u795e\u6238\u56fd\u969b\u5c55\u793a\u5834\u30fb\u795e\u6238\u56fd\u969b\u4f1a\u8b70\u5834\u30fb\u795e\u6238\u30dd\u30fc\u30c8\u30d4\u30a2\u30db\u30c6\u30eb)<\/li>\n<li>\u9ad8\u57ce\u4e00\u90ce, \u7b67\u6625\u5948, \u798f\u7530\u771f\u5f13, \u5e73\u539f\u5eb7\u5bff, \u4f50\u4f2f\u88d5\u4e8c, \u5ca1\u5c71\u662d\u5f66.\u5ca1\u5c71\u662d\u5f66. \u4e73\u5150\u5165\u9662\u5f8c\u306b\u6bcd\u89aa\u306e\u6d3b\u52d5\u6027\u80ba\u7d50\u6838\u7f79\u60a3\u304c\u5224\u660e\u3057\u305f\u4e8b\u4f8b\u3078\u306e\u5bfe\u5fdc. \u7b2c32\u56de\u65e5\u672c\u74b0\u5883\u611f\u67d3\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a. \u7d50\u68382, 2-P2-5. 2017. (2\u670824-25\u65e5(25\u65e5\u767a\u8868), \u5175\u5eab\u770c\u795e\u6238\u5e02, \u795e\u6238\u56fd\u969b\u5c55\u793a\u5834\u30fb\u795e\u6238\u56fd\u969b\u4f1a\u8b70\u5834\u30fb\u795e\u6238\u30dd\u30fc\u30c8\u30d4\u30a2\u30db\u30c6\u30eb)<\/li>\n<li>\u3053\u3082\u53e3\u670b\u6075, \u5c71\u7530\u660e\u8f1d, \u52a0\u6765\u6075, \u6b66\u7530\u5c55\u5e78, \u6885\u6728\u4e00\u7f8e, \u4f50\u4f2f\u88d5\u4e8c, \u5c71\u672c\u6210\u90ce, \u6a2a\u5c71\u8cb4\u88d5, \u5ca1\u5c71\u662d\u5f66.\u3000 Aggregatibacter aphrophilus\u306b\u3088\u308b\u8133\u81bf\u760d\u306e1\u4f8b.\u3000 \u7b2c62\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a \u7b2c28\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u7dcf\u4f1a. \u4e00\u822c\u6f14\u984c \u611f\u67d3\u75c7\u30fb\u5fae\u751f\u72692, 22. 2017. (3\u67084\u65e5, \u798f\u5ca1\u770c\u4e45\u7559\u7c73\u5e02, \u4e45\u7559\u7c73\u5927\u5b66\u75c5\u9662\u3000\u7b51\u6c34\u4f1a\u9928)<\/li>\n<li>\u5c3e\u65b9\u7f8e\u5e78, \u9b3c\u585a\u4e45\u5145, \u6851\u539f\u5f69, \u6b66\u7530\u6075\u7f8e\u5b50, \u9234\u6728\u5343\u4ee3\u5b50, \u798f\u7530\u667a\u5b50, \u5c71\u672c\u6210\u90ce, \u77f3\u5ddd\u54f2\u61b2, \u5ca1\u5c71\u662d\u5f66. \u5fc3\u4e0d\u5168\u3092\u5951\u6a5f\u306b\u8a3a\u65ad\u3055\u308c\u305f\u3001\u8457\u660e\u306a\u5de6\u5ba4\u58c1\u80a5\u539a\u3092\u5448\u3059\u308b\u30df\u30c8\u30b3\u30f3\u30c9\u30ea\u30a2\u5fc3\u7b4b\u75c7\u306e1\u4f8b. \u7b2c62\u56de\u65e5\u672c\u81e8\u5e8a\u691c\u67fb\u533b\u5b66\u4f1a\u4e5d\u5dde\u5730\u65b9\u4f1a \u7b2c28\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u4e5d\u5dde\u652f\u90e8\u7dcf\u4f1a. \u4e00\u822c\u6f14\u984c \u751f\u7406\u6a5f\u80fd2, 26. 2017. (3\u67084\u65e5, \u798f\u5ca1\u770c\u4e45\u7559\u7c73\u5e02, \u4e45\u7559\u7c73\u5927\u5b66\u75c5\u9662\u3000\u7b51\u6c34\u4f1a\u9928<\/li>\n<li>Hashikura Y, Umeki K, Umekita K, Nomura H, Yamada A, Yamamoto I, Hasegawa H, Yanagihara K, Okayama A.\u3000 Infection of Defective Human T-Lymphotropic Virus Type 1 Virus.\u3000 \u7b2c18\u56de\u56fd\u969b\u30d2\u30c8\u30ec\u30c8\u30ed\u30a6\u30a4\u30eb\u30b9HTLV\u4f1a\u8b70.\u3000 Poster P-B Virology, P-B-3.\u3000 2017. (3\u67087-10\u65e5\uff087\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u30db\u30c6\u30eb\u30b0\u30e9\u30f3\u30c9\u30a2\u30fc\u30af\u534a\u8535\u9580)<\/li>\n<li>Umeki K, Hashikura Y, Yamada\u3000A, Yamamoto I, Umekita K, Hamaguchi I, Okayama A. Validity of Polymerase Chain Reaction and Line Immunoassay for Detection of Human T-lymphotropic Virus Type 1 (HTLV-1) Infection on Indeterminate Cases by Western Blot. \u7b2c18\u56de\u56fd\u969b\u30d2\u30c8\u30ec\u30c8\u30ed\u30a6\u30a4\u30eb\u30b9HTLV\u4f1a\u8b70. Poster P-C Infection Control &amp; Laboratory Tests, P-C-3. 2017. (3\u67087-10\u65e5\uff087\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u30db\u30c6\u30eb\u30b0\u30e9\u30f3\u30c9\u30a2\u30fc\u30af\u534a\u8535\u9580)<\/li>\n<li>Umekita K, Hashikura Y, Umeki K, Yamamoto I, Nomura H, Okayama A. Exosome Derived From HTLV-1 Infected Cell Acts As Inflammatory Mediator to Rheumatoid Arthritis Synovial Fibroblast. \u7b2c18\u56de\u56fd\u969b\u30d2\u30c8\u30ec\u30c8\u30ed\u30a6\u30a4\u30eb\u30b9HTLV\u4f1a\u8b70. Poster P-E Clinical Research (HAM\/TSP\uff06Inflammatory Condition), P-E-2. 2017. (3\u67087-10\u65e5\uff087\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u30db\u30c6\u30eb\u30b0\u30e9\u30f3\u30c9\u30a2\u30fc\u30af\u534a\u8535\u9580)<\/li>\n<li>Hashiba Y, Umekita K, Hidaka T, Kai Y, Miyauchi S, Hashikura Y, Umeki K, Yamamoto I, Nomura H, Okayama A. Remission of Smoldering ATL in a Patient with Rheumatoid Arthritis by The Discontinuation of Methotrexate with Anti-TNFa Biologics Combination Therapy: A Case Report. \u7b2c18\u56de\u56fd\u969b\u30d2\u30c8\u30ec\u30c8\u30ed\u30a6\u30a4\u30eb\u30b9HTLV\u4f1a\u8b70. Poster P-E Clinical Research (HAM\/TSP\uff06Inflammatory Condition), P-E-14. 2017. (3\u67087-10\u65e5\uff087\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u30db\u30c6\u30eb\u30b0\u30e9\u30f3\u30c9\u30a2\u30fc\u30af\u534a\u8535\u9580)<\/li>\n<li>Fukui S, Nakamura H, Takahashi Y, Iwamoto N, Hasegawa H, Yanagihara K, Nakamura T, Okayama A, Kawakami A. Biologics Have No Effects to Human T-Lymphotropic Virus type-1(HTLV-1)-Infected\u3000Cell Line from a Patient with HTLV-1-Associated Myelopathy. \u7b2c18\u56de\u56fd\u969b\u30d2\u30c8\u30ec\u30c8\u30ed\u30a6\u30a4\u30eb\u30b9HTLV\u4f1a\u8b70. Poster P-F Immunology, P-F-6. 2017. (3\u67087-10\u65e5\uff087\u65e5\u767a\u8868\uff09, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u30db\u30c6\u30eb\u30b0\u30e9\u30f3\u30c9\u30a2\u30fc\u30af\u534a\u8535\u9580)<\/li>\n<li>\u6885\u5317\u90a6\u5f66, \u65e5\u9ad8\u5229\u5f66, \u5bae\u5185\u4fca\u4e00, \u6a4b\u5834\u5f25\u751f, \u4e45\u4fdd\u548c\u7fa9, \u677e\u7530\u57fa\u5f18, \u6cb3\u91ce\u5f69\u5b50, \u5c0f\u6751\u771f\u592e, \u5ca9\u5c3e\u6d69\u662d, \u9ad8\u57ce\u4e00\u90ce, \u897f\u82f1\u5b50, \u7532\u6590\u6cf0\u6587 \u9577\u53cb\u5b89\u5f18,\u3000\u5ca1\u5c71\u662d\u5f66. HTLV-1\u967d\u6027\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u60a3\u8005\u306e\u81e8\u5e8a\u7684\u691c\u8a0e. \u7b2c53\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u4e00\u822c\u6f14\u984c 7 RA\u3000O-7-4. 2017. (3\u670811-12\u65e5\uff0811\u65e5\u767a\u8868\uff09, \u5927\u5206\u770c\u5225\u5e9c\u5e02, \u5225\u5e9c\u30d3\u30fc\u30b3\u30f3\u30d7\u30e9\u30b6)<\/li>\n<li>\u65e5\u9ad8\u5229\u5f66, \u897f\u82f1\u5b50,\u3000\u6a4b\u5834\u5f25\u751f, \u7532\u6590\u6cf0\u6587, \u9ed2\u7530\u5b8f. \u5f53\u9662\u306b\u304a\u3051\u308b\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u5bfe\u3059\u308bIguratimod \u306e\u6cbb\u7642\u52b9\u679c. \u7b2c53\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u4e3b\u984c1-3 \u30ea\u30a6\u30de\u30c1\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308b\u65b0\u898f\u6cbb\u7642\u85ac\u306e\u4f7f\u7528\u7d4c\u9a13\u300cTofa, IGU\u300d\u3000S-1-19. 2017. (3\u670811-12\u65e5\uff0812\u65e5\u767a\u8868\uff09, \u5927\u5206\u770c\u5225\u5e9c\u5e02, \u5225\u5e9c\u30d3\u30fc\u30b3\u30f3\u30d7\u30e9\u30b6)<\/li>\n<li>\u6a4b\u5834\u5f25\u751f, \u897f\u82f1\u5b50, \u7532\u6590\u6cf0\u6587, \u9ed2\u7530\u5b8f, \u6885\u5317\u90a6\u5f66, \u65e5\u9ad8\u5229\u5f66, \u5ca1\u5c71\u662d\u5f66. \u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u5bfe\u3059\u308b\u30a4\u30f3\u30d5\u30ea\u30ad\u30b7\u30de\u30d6\u6cbb\u7642\u4e2d\u306b\u767a\u75c7\u3057\u305f\u304f\u3059\u3076\u308a\u578bATL\u306e1\u4f8b. \u7b2c53\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u4e00\u822c\u6f14\u984c8\u751f\u7269\u5b66\u7684\u88fd\u52642, 0-8-4. 2017. (3\u670811-12\u65e5\uff0812\u65e5\u767a\u8868\uff09, \u5927\u5206\u770c\u5225\u5e9c\u5e02, \u5225\u5e9c\u30d3\u30fc\u30b3\u30f3\u30d7\u30e9\u30b6)<\/li>\n<li>\u6cb3\u91ce\u5f69\u5b50, \u6885\u5317\u90a6\u5f66, \u529b\u6b66\u771f\u592e, \u5ca9\u5c3e\u6d69\u662d, \u677e\u7530\u57fa\u5f18, \u4e45\u4fdd\u548c\u7fa9, \u5bae\u5185\u4fca\u4e00, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u51fa\u7523\u3092\u5951\u6a5f\u306b\u30eb\u30fc\u30d7\u30b9\u8102\u80aa\u7e54\u708e\u3067\u518d\u71c3\u3057\u305fSLE\u306e1\u4f8b. \u7b2c53\u56de\u4e5d\u5dde\u30ea\u30a6\u30de\u30c1\u5b66\u4f1a. \u30dd\u30b9\u30bf\u30fc\u30bb\u30c3\u30b7\u30e7\u30f31 SLE, P-1-3. 2017. (3\u670811-12\u65e5\uff0812\u65e5\u767a\u8868\uff09, \u5927\u5206\u770c\u5225\u5e9c\u5e02, \u5225\u5e9c\u30d3\u30fc\u30b3\u30f3\u30d7\u30e9\u30b6)<\/li>\n<\/ol>\n<h4>\u3010\u7814\u7a76\u4f1a\u767a\u8868\u3011<\/h4>\n<ol>\n<li>\u5ddd\u7530\u5343\u7d18, \u6885\u5317\u90a6\u5f66. \u591a\u767a\u8840\u7ba1\u708e\u6027\u8089\u82bd\u816b\u75c7\u306e\u6cbb\u7642\u4e2d\u306b\u76ae\u819a\u6f70\u760d\u3092\u6765\u305f\u3057\u305f\u4e00\u4f8b. \u7b2c13\u56de\u5148\u7aef\u533b\u7642\u30bb\u30df\u30ca\u30fc. 2016. \uff087\u67082\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, MRTmicc\uff09<\/li>\n<li>\u5927\u5cf6\u826f, \u9ad8\u57ce\u4e00\u90ce. \u30a4\u30f3\u30c9\u304b\u3089\u306e\u5e30\u56fd\u5f8c\u306b\u767a\u71b1\u3092\u6765\u305f\u3057\u305f\u4f1d\u67d3\u6027\u5358\u6838\u7403\u75c7\u306e\u4e00\u4f8b. \u7b2c13\u56de\u5148\u7aef\u533b\u7642\u30bb\u30df\u30ca\u30fc. 2016. \uff087\u67082\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, MRTmicc\uff09<\/li>\n<li>\u529b\u6b66\u96c4\u5e79, \u6885\u5317\u90a6\u5f66. \u7b4b\u30b8\u30b9\u30c8\u30ed\u30d5\u30a3\u30fc\u306e\u9451\u5225\u306b\u82e6\u616e\u3057\u305f\u6297SRP\u6297\u4f53\u967d\u6027\u7b4b\u75c7\u306e\u4e00\u4f8b. \u7b2c13\u56de\u5148\u7aef\u533b\u7642\u30bb\u30df\u30ca\u30fc. 2016. \uff087\u67082\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, MRTmicc\uff09<\/li>\n<li>\u5bae\u5185\u4fca\u4e00, \u5ca9\u5c3e\u6d69\u662d, \u5c0f\u6751\u771f\u592e, \u6cb3\u91ce\u5f69\u5b50, \u677e\u7530\u57fa\u5f18, \u4e45\u4fdd\u548c\u7fa9, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u30af\u30e9\u30ea\u30b9\u30ed\u30de\u30a4\u30b7\u30f3\u3067\u52a0\u7642\u4e2d\u306e\u539f\u767a\u6027\u7dda\u6bdb\u6a5f\u80fd\u4e0d\u5168\u75c7\u306e\u4e00\u4f8b. \u7b2c18\u56de\u5bae\u5d0e\u300c\u611f\u67d3\u3068\u514d\u75ab\u300d\u7814\u7a76\u4f1a. \u4e00\u822c\u6f14\u984c \u2461. 2016. (11\u67082\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u89b3\u5149\u30db\u30c6\u30eb)<\/li>\n<li>\u6885\u5317\u90a6\u5f66, \u5bae\u5185\u4fca\u4e00, \u4e45\u4fdd\u548c\u7fa9, \u6cb3\u91ce\u5f69\u5b50, \u529b\u6b66\u771f\u592e, \u5ca9\u5c3e\u6d69\u662d, \u677e\u7530\u57fa\u5f18, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u98df\u9053\u6f70\u760d\u3092\u4f34\u3063\u305f\u8840\u7ba1\u30d9\u30fc\u30c1\u30a7\u30c3\u30c8\u306e1\u4f8b. \u30d9\u30fc\u30c1\u30a7\u30c3\u30c8\u75c5\u30d5\u30a9\u30fc\u30e9\u30e0in\u5bae\u5d0e. 2017. \uff081\u670825\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u89b3\u5149\u30db\u30c6\u30eb\uff09<\/li>\n<li>\u5ca1\u5c71\u662d\u5f66. \u75c7\u72b6\u3068\u691c\u67fb\u304b\u3089\u8003\u3048\u308b \u81a0\u539f\u75c5\u306e\u8a3a\u65ad. \u7b2c2\u56de\u81ea\u5df1\u514d\u75ab\u304c\u95a2\u4e0e\u3059\u308b\u80ba\u75be\u60a3\u3068\u691c\u67fb. 2017. \uff081\u670828\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u516b\u767e\u6cbb\u535a\u591a\u30db\u30c6\u30eb\uff09<\/li>\n<li>\u65e5\u9ad8\u5229\u5f66, \u897f\u82f1\u5b50, \u6a4b\u5834\u5f25\u751f, \u7532\u6590\u6cf0\u6587, \u9ed2\u7530\u5b8f. \u5f53\u9662\u306b\u304a\u3051\u308b\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u5bfe\u3059\u308b\u30a4\u30b0\u30e9\u30c1\u30e2\u30c9\u306e\u6cbb\u7642\u52b9\u679c. \u7b2c32\u56de\u5bae\u5d0e\u770c\u30ea\u30a6\u30de\u30c1\u7814\u7a76\u4f1a \u7b2c25\u56de\u5bae\u5d0e\u30ea\u30a6\u30de\u30c1\u306e\u30b1\u30a2\u7814\u7a76\u4f1a. \u2161.\u4e00\u822c\u6f14\u984c 2. 2017. (2\u670811\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02,\u30db\u30c6\u30eb\u30b9\u30ab\u30a4\u30bf\u30ef\u30fc)<\/li>\n<li>\u6885\u5317\u90a6\u5f66, \u5bae\u5185\u4fca\u4e00, \u4eee\u5c4b\u88d5\u7f8e, \u4e45\u4fdd\u548c\u7fa9, \u6cb3\u91ce\u5f69\u5b50, \u529b\u6b66\u771f\u592e, \u5ca9\u5c3e\u6d69\u662d, \u677e\u7530\u57fa\u5f18, \u9ad8\u57ce\u4e00\u90ce, \u9577\u53cb\u5b89\u5f18, \u5ca1\u5c71\u662d\u5f66. \u5bae\u5d0e\u770c\u3067\u306e\u751f\u7269\u5b66\u7684\u88fd\u5264\u306e\u4f7f\u7528\u5b9f\u614b\u8abf\u67fb\u5831\u544a. \u7b2c5\u56de\u5bae\u5d0e\u30ea\u30a6\u30de\u30c1\u52c9\u5f37\u4f1a. session1. 2017. (2\u670817\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u30cb\u30e5\u30fc\u30a6\u30a7\u30eb\u30b7\u30c6\u30a3\u5bae\u5d0e)<\/li>\n<li>\u6a4b\u5834\u5f25\u751f. \u5f53\u9662\u306e\u9ad8\u9f62\u95a2\u7bc0\u30ea\u30a6\u30de\u30c1\u306b\u5bfe\u3059\u308b\u30b4\u30ea\u30e0\u30de\u30d6\u6709\u7528\u6027\u306b\u3064\u3044\u3066. Rheumatology Meeting in Miyazaki\uff5e\u9ad8\u9f62RA\u3078\u306e\u6cbb\u7642\u6226\u7565\uff5e. \u8b1b\u6f14\u30001. 2017. (2\u670822\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u89b3\u5149\u30db\u30c6\u30eb)<\/li>\n<li>\u5ca1\u5c71\u662d\u5f66. \u74b0\u5883\u3068\u771f\u83cc\u611f\u67d3\u75c7\uff5e\u75c5\u9662\u65bd\u8a2d\u6539\u4fee\u6642\u306e\u30a2\u30b9\u30da\u30eb\u30ae\u30eb\u30b9\u611f\u67d3\u5bfe\u7b56\uff5e. \u7b2c15\u56de\u30ad\u30e3\u30f3\u30c7\u30a3\u30f3\u7814\u7a76\u4f1a. \u611f\u67d3\u5236\u5fa1\u3001\u5916\u79d1\u7cfb\u30fb\u6551\u6025\u30fb\u96c6\u4e2d\u6cbb\u7642\u9818\u57df \u30d4\u30c3\u30c8\u30db\u30fc\u30eb\u3092\u8a9e\u308b\uff01\uff01 2017. (3\u670811\u65e5, \u6771\u4eac\u90fd\u6e2f\u533a, \u30b0\u30e9\u30f3\u30c9\u30d7\u30ea\u30f3\u30b9\u30db\u30c6\u30eb\u65b0\u9ad8\u8f2a)<\/li>\n<\/ol>\n<h4>\u3010\u8b1b\u6f14\u30fb\u30bb\u30df\u30ca\u30fc\u3011<\/h4>\n<ol>\n<li>\u9ad8\u57ce\u4e00\u90ce, \u798f\u7530\u771f\u5f13, \u7b67\u6625\u5948. \u611f\u67d3\u5bfe\u7b56\u306b\u3064\u3044\u3066. \u5e73\u621028\u5e74\u5ea6\u533b\u54e1\uff08\u7814\u4fee\u533b\uff09\u30aa\u30ea\u30a8\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3. 2016. \uff084\u67087\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\uff09<\/li>\n<li>\u9ad8\u57ce\u4e00\u90ce. \u6297\u83cc\u85ac\u6cbb\u7642\u306b\u3064\u3044\u3066. 2016. \uff084\u670813\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, Meiji Seika\u30d5\u30a1\u30eb\u30de\uff09<\/li>\n<li>\u9577\u53cb\u5b89\u5f18. \u691c\u67fb\u5024\u306e\u898b\u65b9\u3068\u89e3\u91c8. \u307f\u3084\u3056\u304d\u85ac\u85ac\u9023\u643a\u5168\u4f53\u7814\u4fee\u4f1a\u3000\u5e73\u621028\u5e74\u5ea6\u7b2c1\u56de\u751f\u6daf\u5b66\u7fd2\u7814\u4fee\u4f1a. 2016. \uff084\u670817\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, JA\u30fbAZM\u30db\u30fc\u30eb\uff09<\/li>\n<li>\u9ad8\u57ce\u4e00\u90ce, \u798f\u7530\u771f\u5f13, \u7b67\u6625\u5948. \u9662\u5185\u611f\u67d3. \u5e73\u621028\u5e74\u5ea6\u533b\u5b66\u79d11\u5e74\u751f\u5b66\u5185\u65e9\u671f\u4f53\u9a13\u5b9f\u7fd2. 2016. \uff084\u670822\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\u9644\u5c5e\u75c5\u9662\uff09<\/li>\n<li>\u5ca1\u5c71\u662d\u5f66. \u9662\u5185\u611f\u67d3\u5bfe\u7b56\u30a2\u30c3\u30d7\u30c7\u30fc\u30c8. \u7b2c13\u56de\u900f\u6790\u7642\u6cd5\u3068\u5b89\u5168\u7ba1\u7406\u30bb\u30df\u30ca\u30fc. 2016. \uff085\u670828\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a\u9928\uff09<\/li>\n<li>\u5ca1\u5c71\u662d\u5f66. \u611f\u67d3\u5bfe\u7b56\u306b\u304a\u3051\u308b\u691c\u67fb\u6280\u5e2b\u306e\u5f79\u5272. \u5e73\u621028\u5e74\u5ea6\uff08\u4e00\u793e\uff09\u5bae\u5d0e\u770c\u81e8\u5e8a\u691c\u67fb\u6280\u5e2b\u4f1a\u5b9a\u671f\u7dcf\u4f1a. 2016. \uff086\u67085\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u770c\u7acb\u5bae\u5d0e\u75c5\u9662\uff09<\/li>\n<li>\u5ca1\u5c71\u662d\u5f66. \u773c\u75be\u60a3\u3092\u4f34\u3044\u3084\u3059\u3044\u81a0\u539f\u75c5\u53ca\u3073\u985e\u7e01\u75be\u60a3\u306e\u5185\u79d1\u7684\u898b\u65b9. \u7b2c78\u56de\u5bae\u5d0e\u5927\u5b66\u773c\u79d1\u7814\u7a76\u4f1a. 2016. \uff087\u670816\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u89b3\u5149\u30db\u30c6\u30eb\uff09<\/li>\n<li>\u5ca1\u5c71\u662d\u5f66. \u611f\u67d3\u75c7\u57fa\u790e\uff08\u6613\u611f\u67d3\u72b6\u614b\uff09. \u5e73\u621028\u5e74\u5ea6\u30bb\u30ec\u30af\u30c8\u30b3\u30fc\u30b9IC\u30d7\u30ed\u30b0\u30e9\u30e0. 2016. \uff087\u670829\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u9644\u5c5e\u75c5\u9662\uff09<\/li>\n<li>\u9ad8\u57ce\u4e00\u90ce. \u75c5\u9662\u3067\u554f\u984c\u3068\u306a\u308b\u8010\u6027\u83cc. \u5e73\u621028\u5e74\u5ea6\u30bb\u30ec\u30af\u30c8\u30b3\u30fc\u30b9IC\u30d7\u30ed\u30b0\u30e9\u30e0. 2016. \uff088\u670826\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u9644\u5c5e\u75c5\u9662\uff09<\/li>\n<li>\u9ad8\u57ce\u4e00\u90ce. \u8077\u696d\u611f\u67d3\u9632\u6b62\u5bfe\u7b56\uff084\u7a2e\u30a6\u30a4\u30eb\u30b9, \u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\uff09. \u5e73\u621028\u5e74\u5ea6\u30bb\u30ec\u30af\u30c8\u30b3\u30fc\u30b9IC\u30d7\u30ed\u30b0\u30e9\u30e0. 2016. \uff088\u670826\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u9644\u5c5e\u75c5\u9662\uff09<\/li>\n<li>\u9ad8\u57ce\u4e00\u90ce. \u8010\u6027\u83cc\u611f\u67d3\u75c7\u306e\u8a3a\u65ad\u3068\u6cbb\u7642\u3068\u4e88\u9632. \u5bae\u5d0e\u770c\u7acb\u770b\u8b77\u5927\u5b66\u5e73\u621028\u5e74\u5ea6\u770b\u8b77\u7814\u7a76\u30fb\u7814\u4fee\u30bb\u30f3\u30bf\u30fc\u611f\u67d3\u7ba1\u7406\u8a8d\u5b9a\u770b\u8b77\u5e2b\u6559\u80b2\u8ab2\u7a0b. 2016. \uff088\u670830\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u770c\u7acb\u770b\u8b77\u5927\u5b66\uff09<\/li>\n<li>\u5ca1\u5c71\u662d\u5f66. \u30d2\u30c8\u514d\u75ab\u4e0d\u5168\u30a6\u30a4\u30eb\u30b9\uff08human immunodeficiency virus : HIV\uff09\u611f\u67d3\u75c7. \u5bae\u5d0e\u770c\u7acb\u770b\u8b77\u5927\u5b66\u5e73\u621028\u5e74\u5ea6\u770b\u8b77\u7814\u7a76\u30fb\u7814\u4fee\u30bb\u30f3\u30bf\u30fc\u611f\u67d3\u7ba1\u7406\u8a8d\u5b9a\u770b\u8b77\u5e2b\u6559\u80b2\u8ab2\u7a0b. 2016. \uff088\u670830\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u770c\u7acb\u770b\u8b77\u5927\u5b66\uff09<\/li>\n<li>\u9ad8\u57ce\u4e00\u90ce. \u611f\u67d3\u5236\u5fa1\u90e8\u3067\u306e\u6d3b\u52d5\u3001\u6297\u83cc\u85ac\u9069\u6b63\u4f7f\u7528\u306a\u3069\u306b\u3064\u3044\u3066. \u793e\u5185\u7814\u4fee\u4f1a\u3000\u547c\u5438\u5668\u75be\u60a3\u306e\u8a3a\u65ad\u3068\u6cbb\u7642+LM. 2016. \uff088\u670831\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u30a2\u30b9\u30c6\u30e9\u30b9\u88fd\u85ac\u5bae\u5d0e\u55b6\u696d\u6240\uff09<\/li>\n<li>\u9577\u53cb\u5b89\u5f18. \u80ba\u708e\u7403\u83cc\u30ef\u30af\u30c1\u30f3\u3092\u901a\u3057\u3066\u5b66\u3093\u3060\u3053\u3068. \u80ba\u708e\u7403\u83cc\u30ef\u30af\u30c1\u30f3\u3000\u611f\u67d3\u75c7\u5b66\u8853\u8b1b\u6f14\u4f1a. 2016. (9\u670816\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, KITEN\u30d3\u30eb)<\/li>\n<li>\u9ad8\u57ce\u4e00\u90ce. \u8077\u696d\u611f\u67d3\u9632\u6b62\u5bfe\u7b56\uff08\u7d50\u6838, HIV, HBV\uff09. \u5e73\u621028\u5e74\u5ea6\u30bb\u30ec\u30af\u30c8\u30b3\u30fc\u30b9IC\u30d7\u30ed\u30b0\u30e9\u30e0. 2016. \uff089\u670830\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u9644\u5c5e\u75c5\u9662\uff09<\/li>\n<li>\u5ca1\u5c71\u662d\u5f66. \u672c\u9662\u306b\u304a\u3051\u308b\u611f\u67d3\u5bfe\u7b56\uff1aup-to-date. \u5e73\u621028\u5e74\u5ea6\u7b2c4\u56de\u533b\u7642\u5b89\u5168\u7ba1\u7406\u30fb\u611f\u67d3\u5bfe\u7b56\u8b1b\u6f14\u4f1a. \u2461\u611f\u67d3\u5bfe\u7b56\u90e8\u9580. 2016. (10\u67083\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u9644\u5c5e\u75c5\u9662)<\/li>\n<li>\u9577\u53cb\u5b89\u5f18, \u5ca9\u5c3e\u6d69\u662d, \u5c0f\u6751\u771f\u592e, \u6cb3\u91ce\u5f69\u5b50, \u677e\u7530\u57fa\u5f18, \u4e45\u4fdd\u548c\u7fa9, \u5bae\u5185\u4fca\u4e00, \u6885\u5317\u90a6\u5f66, \u9ad8\u57ce\u4e00\u90ce, \u5ca1\u5c71\u662d\u5f66. \u5168\u8eab\u6027\u5f37\u76ae\u75c7\u5408\u4f75\u6c17\u7ba1\u652f\u5598\u606f\u306b\u5bfe\u3057\u3066\u30d5\u30eb\u30c6\u30a3\u30d5\u30a9\u30fc\u30e0\u3092\u6295\u4e0e\u3057\u305f1\u4f8b. \u7b2c2\u56de\u547c\u5438\u5668\u30bb\u30df\u30ca\u30fc\u5bae\u5d0e. \u4e00\u822c\u6f14\u984c. 2016. (10\u67085\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u89b3\u5149\u30db\u30c6\u30eb)<\/li>\n<li>\u9ad8\u57ce\u4e00\u90ce. \u5f53\u9662\u306e\u8010\u6027\u83cc\u5bfe\u7b56\u306b\u3064\u3044\u3066. MRSA\u611f\u67d3\u75c7\u3000\u5b66\u8853\u8b1b\u6f14\u4f1a. Session \u2160. 2016. (12\u670821\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, MRT micc)<\/li>\n<li>\u5ca1\u5c71\u662d\u5f66. \u5185\u79d1\u533b\u304c\u77e5\u308a\u305f\u3044\u691c\u67fb\u3068\u7cbe\u5ea6. \u5e73\u621028\u5e74\u5ea6(\u7b2c41\u56de)\u9577\u5d0e\u770c\u533b\u5e2b\u4f1a\u81e8\u5e8a\u691c\u67fb\u7cbe\u5ea6\u7ba1\u7406\u7814\u4fee\u4f1a. \u7279\u5225\u8b1b\u6f14. 2017. (3\u670818\u65e5, \u9577\u5d0e\u770c\u9577\u5d0e\u5e02, \u9577\u5d0e\u770c\u533b\u5e2b\u4f1a\u9928)<\/li>\n<li>\u5ca1\u5c71\u662d\u5f66. HTLV-1\u611f\u67d3\u75c7\u306b\u3064\u3044\u3066. \u5e73\u621028\u5e74\u5ea6HTLV-1\u6bcd\u5b50\u611f\u67d3\u5bfe\u7b56\u4e8b\u696d\u7814\u4fee\u4f1a. \u7279\u5225\u8b1b\u6f14\u2161. 2017. (3\u670825\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u770c\u533b\u5e2b\u4f1a)<\/li>\n<\/ol>\n<h4>\u3010\u305d\u306e\u4ed6\u3011<\/h4>\n<ol>\n<li>\u6885\u5317\u90a6\u5f66. HTLV-1\u611f\u67d3\u7d30\u80de\u306b\u3088\u308b\u30ea\u30a6\u30de\u30c1\u6ed1\u819c\u7d30\u80de\u306e\u6d3b\u6027\u5316\u6a5f\u69cb\u306e\u691c\u8a0e\u3068\u9577\u5d0e-\u5bae\u5d0eHTLV-1RA\u30ec\u30b8\u30b9\u30c8\u30ea\u306e\u9032\u6357\u72b6\u6cc1\u306b\u3064\u3044\u3066. 2016\u5e74\u5ea6\u65e5\u672c\u533b\u7642\u7814\u7a76\u958b\u767a\u6a5f\u69cb\u7814\u7a76\u8cbb\uff08\u96e3\u6cbb\u6027\u75be\u60a3\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d\uff09\u3000HTLV-1\u967d\u6027\u96e3\u6cbb\u6027\u75be\u60a3\u306e\u8a3a\u7642\u306e\u8cea\u3092\u9ad8\u3081\u308b\u305f\u3081\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u69cb\u7bc9 \u7b2c1\u56de\u5ca1\u5c71\u73ed\u73ed\u4f1a\u8b70. 2016. \uff085\u670815\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, \u5bae\u5d0e\u5927\u5b66\u533b\u5b66\u90e8\uff09<\/li>\n<li>\u5ca1\u5c71\u662d\u5f66. HTLV-1\u967d\u6027\u96e3\u6cbb\u6027\u30ea\u30a6\u30de\u30c1\u6027\u75be\u60a3\u306e\u5bfe\u5fdc\u306b\u3064\u3044\u3066. \u5e73\u621028\u5e74\u5ea6\u3000\u7b2c\uff11\u56de\u5c71\u91ce\u73ed\u5408\u540c\u73ed\u4f1a\u8b70. 2016. \uff086\u670826\u65e5, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u30db\u30c6\u30eb\u30b0\u30e9\u30f3\u30c9\u30a2\u30fc\u30af\u534a\u8535\u9580\uff09<\/li>\n<li>\u5ca1\u5c71\u662d\u5f66. HTLV-1\u611f\u67d3\u8005\u304a\u3088\u3073\u95a2\u9023\u75be\u60a3\u60a3\u8005\u306b\u5408\u4f75\u3059\u308b\u708e\u75c7\u6027\u75be\u60a3\u306e\u708e\u75c7\u4fc3\u9032\u56e0\u5b50\u306e\u63a2\u7d22. \u81e8\u5e8a\u30b2\u30ce\u30e0\u60c5\u5831\u7d71\u5408\u30c7\u30fc\u30bf\u30d9\u30fc\u30b9\u6574\u5099\u4e8b\u696d\u3000\u300c\u30d2\u30c8\u3068\u30a6\u30a4\u30eb\u30b9\u306e\u30b2\u30ce\u30e0\u60c5\u5831\u3068\u81e8\u5e8a\u60c5\u5831\u306e\u7d71\u5408\u306b\u3088\u308bHTLV-1\u95a2\u9023\u75be\u60a3\u306e\u8a3a\u7642\u652f\u63f4\u5168\u56fd\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u306e\u78ba\u7acb\u300d \u30ad\u30c3\u30af\u30aa\u30d5\u4f1a\u8b70. 2016. \uff089\u670818\u65e5, \u6771\u4eac\u90fd\u4e2d\u592e\u533a, \u65e5\u672c\u6a4b\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u30d3\u30eb\uff09<\/li>\n<li>\u6885\u5317\u90a6\u5f66.\u3000 HTLV-1\u967d\u6027RA\u30b3\u30db\u30fc\u30c8\u304b\u3089\u307f\u3048\u308b\u8ab2\u984c\uff5ein vitro\u306e\u691c\u8a0e\u3092\u8e0f\u307e\u3048\u3066\uff5e.\u30002016\u5e74\u5ea6\u65e5\u672c\u533b\u7642\u7814\u7a76\u958b\u767a\u6a5f\u69cb\u7814\u7a76\u8cbb(\u96e3\u6cbb\u6027\u75be\u60a3\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d)HTLV-1\u967d\u6027\u96e3\u6cbb\u6027\u75be\u60a3\u306e\u8a3a\u7642\u306e\u8cea\u3092\u9ad8\u3081\u308b\u305f\u3081\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u69cb\u7bc9\u3000\u5ca1\u5c71\u73ed\u7b2c2\u56de\u73ed\u4f1a\u8b70.\u3000 2016. (10\u670830\u65e5, \u6771\u4eac\u90fd\u6e2f\u533a, \u6771\u4eac\u5927\u5b66\u533b\u79d1\u5b66\u7814\u7a76\u6240)<\/li>\n<li>\u5ca1\u5c71\u662d\u5f66.\u3000 HTLV-1\u967d\u6027\u96e3\u6cbb\u6027\u75be\u60a3\u306e\u8a3a\u7642\u306e\u8cea\u3092\u9ad8\u3081\u308b\u305f\u3081\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u69cb\u7bc9.\u30002016\u5e74\u5ea6\u65e5\u672c\u533b\u7642\u7814\u7a76\u958b\u767a\u6a5f\u69cb\u7814\u7a76\u8cbb(\u96e3\u6cbb\u6027\u75be\u60a3\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d)HTLV-1\u967d\u6027\u96e3\u6cbb\u6027\u75be\u60a3\u306e\u8a3a\u7642\u306e\u8cea\u3092\u9ad8\u3081\u308b\u305f\u3081\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u69cb\u7bc9\u3000\u5ca1\u5c71\u73ed\u7b2c2\u56de\u73ed\u4f1a\u8b70.\u3000 2016. (10\u670830\u65e5, \u6771\u4eac\u90fd\u6e2f\u533a, \u6771\u4eac\u5927\u5b66\u533b\u79d1\u5b66\u7814\u7a76\u6240)<\/li>\n<li>\u5ca1\u5c71\u662d\u5f66. HTLV-1\u967d\u6027\u96e3\u6cbb\u6027\u75be\u60a3\u306e\u8a3a\u7642\u306e\u8cea\u3092\u9ad8\u3081\u308b\u305f\u3081\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u69cb\u7bc9 \u96e3\u6cbb\u6027\u6162\u6027\u708e\u75c7\u6027\u75be\u60a3HTLV-1\u611f\u67d3. \u5e73\u621028\u5e74\u5ea6\u539a\u751f\u52b4\u50cd\u79d1\u5b66\u7814\u7a76\u8cbb\uff06AMED\u300cHTLV-1\u95a2\u9023\u75be\u60a3\u7814\u7a76\u9818\u57df\u300d\u7814\u7a76\u73ed\u5408\u540c\u767a\u8868\u4f1a. Session\u2162. 2017. (2\u67084\u65e5, \u6771\u4eac\u90fd\u6e2f\u533a, \u6771\u4eac\u5927\u5b66\u533b\u79d1\u5b66\u7814\u7a76\u6240)<\/li>\n<li>\u5ca1\u5c71\u662d\u5f66, \u5ddd\u4e0a\u7d14, \u6e21\u908a\u4fca\u6a39, \u5ca9\u6c38\u6b63\u5b50, \u9d28\u5c45\u529f\u6a39, \u5c71\u91ce\u5609\u4e45. HTLV-1\u967d\u6027\u96e3\u6cbb\u6027\u75be\u60a3\u65b0\u826f\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u4f5c\u6210\u3092\u76ee\u6307\u3059\u30a8\u30d3\u30c7\u30f3\u30b9\u69cb\u7bc9. HTLV-1\u967d\u6027\u96e3\u6cbb\u6027\u75be\u60a3\u306e\u8a3a\u7642\u306e\u8cea\u3092\u9ad8\u3081\u308b\u305f\u3081\u306e\u30a8\u30d3\u30c7\u30f3\u30b9\u69cb\u7bc9. \u96e3\u6cbb\u6027\u75be\u60a3\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d \u514d\u75ab\u30a2\u30ec\u30eb\u30ae\u30fc\u75be\u60a3\u7b49\u5b9f\u7528\u5316\u7814\u7a76\u4e8b\u696d(\u514d\u75ab\u30a2\u30ec\u30eb\u30ae\u30fc\u75be\u60a3\u5b9f\u7528\u5316\u7814\u7a76\u5206\u91ce)2016\u5e74\u5ea6\u5408\u540c\u6210\u679c\u5831\u544a\u4f1a. 2017. (2\u670810\u65e5, \u6771\u4eac\u90fd\u5343\u4ee3\u7530\u533a, \u30a4\u30a4\u30ce\u30db\u30fc\u30eb\uff06\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u30bb\u30f3\u30bf\u30fc)<\/li>\n<\/ol>\n<p>&#8211;<\/p>\n<div class=\"pagetop-entry\"><a href=\"#wrapper\"><img loading=\"lazy\" alt=\"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\" src=\"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/files\/2017\/07\/btn-pagetop1.gif\" width=\"123\" height=\"24\" \/><\/a><\/div>\n<h3 class=\"subjectBasic\">C. \u305d\u306e\u4ed6<\/h3>\n<ol>\n<li>\u9ad8\u57ce\u4e00\u90ce. \u30b8\u30ab\u30a6\u30a4\u30eb\u30b9\u611f\u67d3\u75c7\uff08\u30b8\u30ab\u71b1\uff09\u306b\u3064\u3044\u3066. \u65e5\u5dde\u91ab\u4e8b. 2016; 804: 92-93.<\/li>\n<li>\u5ca1\u5c71\u662d\u5f66. \u51ac\u306e\u611f\u67d3\u75c7\u3092\u5fb9\u5e95\u5bfe\u7b56\uff01\u30a4\u30f3\u30d5\u30eb\u30a8\u30f3\u30b6\u30fb\u30ce\u30ed\u30a6\u30a4\u30eb\u30b9. \u5bae\u5d0e\u5927\u5b66MAGAZINE. 2016; 24: 1-2.<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<p><strong>\u3010\u5b66\u4f1a\u4e3b\u50ac\u7b49\u3011<\/strong><\/p>\n<ol>\n<li>\u4e16\u8a71\u4eba \u5ca1\u5c71\u662d\u5f66. \u7b2c15\u56de\u4e5d\u5dde\u30b7\u30a7\u30fc\u30b0\u30ec\u30f3\u75c7\u5019\u7fa4\u7814\u7a76\u4f1a. 2016. \uff085\u670821\u65e5, \u798f\u5ca1\u770c\u798f\u5ca1\u5e02, \u798f\u5ca1\u770c\u4e2d\u5c0f\u4f01\u696d\u632f\u8208\u30bb\u30f3\u30bf\u30fc\uff09<\/li>\n<li>\u4e16\u8a71\u4eba\u3000\u5ca1\u5c71\u662d\u5f66, \u9ad8\u57ce\u4e00\u90ce. \u7b2c27\u56de\u5bae\u5d0e\u30ea\u30a6\u30de\u30c1\u533b\u306e\u4f1a. 2016. \uff088\u67086\u65e5, \u5bae\u5d0e\u770c\u5bae\u5d0e\u5e02, MRTmicc\uff09<\/li>\n<\/ol>\n<ol><\/ol>\n<p>&#8211;<\/p>\n<div class=\"pagetop-entry\"><a href=\"#wrapper\"><img loading=\"lazy\" alt=\"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\" src=\"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/files\/2017\/07\/btn-pagetop1.gif\" width=\"123\" height=\"24\" \/><\/a><\/div>\n<h3 class=\"subjectBasic\">D. \u7279\u8a31\u51fa\u9858<\/h3>\n<p>&#8211;<\/p>\n<div class=\"pagetop-entry\"><a href=\"#wrapper\"><img loading=\"lazy\" alt=\"\u3053\u306e\u30da\u30fc\u30b8\u306e\u5148\u982d\u3078\" src=\"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/files\/2017\/07\/btn-pagetop1.gif\" width=\"123\" height=\"24\" \/><\/a><\/div>\n<h2 class=\"achievement-account\"><span style=\"font-size: small;\">\u5185\u8a33\u6570\uff082017\u5e746\u67086\u65e5\u6642\u70b9\uff09<\/span><\/h2>\n<p>A.\u8ad6\u6587\uff1a\u8457\u66f8(1), \u539f\u8457(6), \u75c7\u4f8b\u5831\u544a\uff08\u8ad6\u6587\uff09(3), \u7dcf\u8aac\uff083\uff09<br \/>\nB.\u767a\u8868\uff1a\u5b66\u4f1a\u767a\u8868\uff0853\uff09, \u7814\u7a76\u4f1a\u767a\u8868\uff0810\uff09, \u8b1b\u6f14\u30fb\u30bb\u30df\u30ca\u30fc\uff0820\uff09, \u305d\u306e\u4ed6\uff087\uff09<br \/>\nC.\u305d\u306e\u4ed6\uff084\uff09<br \/>\nD.\u7279\u8a31\u51fa\u9858\uff080\uff09<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A. \u8ad6\u6587 \u3010\u8457\u66f8\u3011 \u6885\u5317\u90a6\u5f66, \u5ca1\u5c71\u662d\u5f66. \u7b2c\uff13\u7ae0\u3000\u8a3a\u5bdf\u3068\u691c\u67fb\u306e\u624b\u6280\u3092\u5b66\u3076\u3000B. \u4e00\u822c\u81e8\u5e8a\u691c\u67fb\u3000\uff12. \u672b\u68a2\u8840. \u81a0\u539f\u75c5\u30fb\u30ea\u30a6\u30de\u30c1\u30fb\u30a2\u30ec\u30eb\u30ae\u30fc\u3000\u7814\u4fee\u30ce\u30fc\u30c8. \u8a3a\u65ad\u3068\u6cbb\u7642\u793e, \u6771\u4eac. 2016; 94-95. \u3010\u539f\u8457\u3011 I [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false},"categories":[9],"tags":[],"_links":{"self":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts\/285"}],"collection":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/comments?post=285"}],"version-history":[{"count":0,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/posts\/285\/revisions"}],"wp:attachment":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/media?parent=285"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/categories?post=285"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/menekikansen\/wp-json\/wp\/v2\/tags?post=285"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}